A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent orPersistent Endometrial Cancer

Project: Research project

Project Details

Description

A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent or Persistent Endometrial Cancer
StatusActive
Effective start/end date5/19/215/31/26

Funding

  • ALLIANCE FOUNDATION TRIALS, LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.